Challenges in operationalising clinical trials in India during the COVID-19 pandemic

Affiliations

¹ The George Institute for Global Health, New Delhi, India.
² The George Institute for Global Health, New Delhi, India; Critical Care Program, The George Institute for Global Health, University of New South Wales, Sydney, NSW, Australia; Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia.
³ Critical Care Program, The George Institute for Global Health, University of New South Wales, Sydney, NSW, Australia; Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia; Malcolm Fisher Department of Intensive Care, Royal North Shore Hospital, Sydney, NSW, Australia.
⁴ Critical Care Program, The George Institute for Global Health, University of New South Wales, Sydney, NSW, Australia.
⁵ The George Institute for Global Health, New Delhi, India; Department of Critical Care Medicine, Apollo Hospitals, Chennai, India. Electronic address: bharath@icuconsultants.com.
⁶ Critical Care Program, The George Institute for Global Health, University of New South Wales, Sydney, NSW, Australia; Department of Critical Care, Wesley Hospital, Brisbane, QLD, Australia; Department of Critical Care, University of Queensland, Brisbane, QLD, Australia.
⁷ The George Institute for Global Health, New Delhi, India; School of Public Health, Imperial College London, London, UK; Manipal Academy of Higher Education, Manipal, India.

Review

Abhinav Bassi et al. Lancet Glob Health. 2022 Mar.

. 2022 Mar;10(3):e317-e319.

doi: 10.1016/S2214-109X(21)00546-5. Epub 2021 Dec 22.

¹ The George Institute for Global Health, New Delhi, India.
² The George Institute for Global Health, New Delhi, India; Critical Care Program, The George Institute for Global Health, University of New South Wales, Sydney, NSW, Australia; Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia.
³ Critical Care Program, The George Institute for Global Health, University of New South Wales, Sydney, NSW, Australia; Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia; Malcolm Fisher Department of Intensive Care, Royal North Shore Hospital, Sydney, NSW, Australia.
⁴ Critical Care Program, The George Institute for Global Health, University of New South Wales, Sydney, NSW, Australia.
⁵ The George Institute for Global Health, New Delhi, India; Department of Critical Care Medicine, Apollo Hospitals, Chennai, India. Electronic address: bharath@icuconsultants.com.
⁶ Critical Care Program, The George Institute for Global Health, University of New South Wales, Sydney, NSW, Australia; Department of Critical Care, Wesley Hospital, Brisbane, QLD, Australia; Department of Critical Care, University of Queensland, Brisbane, QLD, Australia.
⁷ The George Institute for Global Health, New Delhi, India; School of Public Health, Imperial College London, London, UK; Manipal Academy of Higher Education, Manipal, India.

No abstract available

Comment in

Complexity of clinical trial operationalisation in India.
Shivabasappa S, Srinivasan A. Shivabasappa S, et al. Lancet Glob Health. 2022 Jul;10(7):e953. doi: 10.1016/S2214-109X(22)00209-1. Lancet Glob Health. 2022. PMID: 35714642 Free PMC article. No abstract available.
Early phase clinical trials in India: Need & scope.
Kshirsagar NA, Pahuja M, Chatterjee NS, Kamboj VP. Kshirsagar NA, et al. Indian J Med Res. 2023 Jan;158(1):17-20. doi: 10.4103/ijmr.ijmr_1688_22. Indian J Med Res. 2023. PMID: 37602581 Free PMC article. No abstract available.

1. Carlisle BG. Clinical trials stopped by COVID-19. The Grey Literature. 2020. https://covid19.bgcarlisle.com/
1. Vijayaraghavan BKT, Jha V, Rajbhandari D, et al. Hydroxychloroquine plus personal protective equipment versus standard personal protective equipment alone for the prevention of COVID-19 infections among frontline healthcare workers: the HydrOxychloroquine Prophylaxis Evaluation (HOPE) trial: a structured summary of a study protocol for a randomized controlled trial. Trials. 2020;21:754. - PMC - PubMed
1. Munch MW, Granholm A, Myatra SN, et al. Higher vs lower doses of dexamethasone in patients with COVID-19 and severe hypoxia (COVID STEROID 2) trial: protocol and statistical analysis plan. Acta Anaesthesiol Scand. 2021;65:834–845. - PMC - PubMed
1. Indian Council of Medical Research National guidelines for ethics committees reviewing biomedical and health research during COVID-19 pandemic. April, 2020. https://www.icmr.gov.in/pdf/covid/techdoc/EC_Guidance_COVID19_06052020.pdf - PubMed
1. Central Drugs Standard Control Organisation New drugs and clinical trials rules, 2019. March 19, 2019. https://cdsco.gov.in/opencms/export/sites/CDSCO_WEB/Pdf-documents/NewDru...